EPCAM and non-small cell lung carcinoma: Frequently reported low or absence of EpCAM on NSCLC cells [54, 55] and active EMT that results in down‐regulation of EpCAM on CTCs [20, 21, 22, 56], may account for the existence of predominant null CTCs in pretherapeutic patients in this study.